1,5-Diarylpyrazole and vanillin hybrids: Synthesis, biological activity and DFT studies

Herein, we report the design and synthesis of 13 diarylpyrazole hybrids with vanillin constructed as dual compounds against oxidative stress and diabetes. Compounds were tested in two different antioxidant assays. It was found that all compounds showed an important antioxidant activity in both DPPH...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 100; pp. 106 - 118
Main Authors Hernández-Vázquez, Eduardo, Castañeda-Arriaga, Romina, Ramírez-Espinosa, Juan José, Medina-Campos, Omar Noel, Hernández-Luis, Francisco, Chaverri, José Pedraza, Estrada-Soto, Samuel
Format Journal Article
LanguageEnglish
Published ISSY-LES-MOULINEAUX Elsevier Masson SAS 15.07.2015
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Herein, we report the design and synthesis of 13 diarylpyrazole hybrids with vanillin constructed as dual compounds against oxidative stress and diabetes. Compounds were tested in two different antioxidant assays. It was found that all compounds showed an important antioxidant activity in both DPPH and ORAC models and the activity was even more remarkable than vanillin. In addition, the hypoglycemic effect of compounds 1, 2, 4 and 12 was evaluated. Interestingly, compound 1 had the most potent hypoglycemic effect with a glycemia reduction of 71%, which was higher than rimonabant. Finally, a DFT study to propose a reasonable antioxidant mechanism is detailed. Both thermodynamic and kinetic studies indicated that the most feasible mechanism consists in the HAT abstraction of the phenolic hydrogen due to the formation of an stable transition state through the most rapid and exergonic path, while the SPLET mechanism is the most significant at higher pH values. [Display omitted] •Pyrazole derivatives were designed and synthesized against oxidative stress and diabetes.•Compounds showed moderate antioxidant activity in both DPPH and ORAC assays.•Analogs tested had an important hypoglycemic reduction, which was higher than rimonabant.•DFT calculations proposed that both HAT and SPLET are involved in antioxidant activity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2015.06.010